Source link : https://newshealth.biz/health-news/adding-lenvatinib-to-pembro-ups-pfs-in-head-and-neck-cancer/
In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously. Medscape Medical News Source link : https://www.medscape.com/viewarticle/adding-lenvatinib-pembro-ups-pfs-head-and-neck-cancer-2026a10008jn?src=rss Author : Publish date : 2026-03-20 11:50:00 Copyright for syndicated content belongs […]
The post Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-20 11:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8